Context Therapeutics and The Menarini Group Announce Clinical Trial Collaboration and Supply Agreement to Evaluate ONA-XR and Elacestrant Combination

Preclinical data support the potential of ONA-XR plus estrogen receptor degraders in endocrine resistant disease models Context to initiate Phase 1b/2 clinical trial in Q4 2022 Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company developing small molecule and immunotherapy treatments for breast and gynecological cancers, and The Menarini Group (“Menarini”)…

thaipr.net

3 ส.ค. 65

FORTUNE RELEASES ANNUAL FORTUNE GLOBAL 500 LIST

2022 Ranking Features 145 Chinese Companies, 124 U.S. Companies, and 47 Japanese Companies  Today, FORTUNE announced the Fortune Global 500TM list for 2022, ranking the world’s largest corporations by revenue for fiscal 2021. Walmart claims the top spot for the ninth consecutive year, and for the 17th time since 1995. Saudi Aramco (No. 6) reclaims its title as the world’s most profitable company, with $105 […]

thaipr.net

3 ส.ค. 65

Toys”R”Us Asia Announces Departure of CEO, Andre Javes; Pieter Schats Appointed as Interim Executive Chairman

Toys”R”Us (Asia) Limited today announced that Chief Executive Officer, Andre Javes, will be leaving the company to pursue other interests, effective August 24, 2022. Pieter Schats, current Chairman of Toys”R”Us Asia’s board of directors and previously the company’s CEO from 2002 to 2014, will serve as Interim Executive Chairman until a permanent Group Chief Executive […]

thaipr.net

3 ส.ค. 65
1 2,129 2,130 2,131 2,132 2,133 3,330